Conversely, in the GABA-glutamate-glutamine cycle, mitochondrial succinic semialdehyde dehydrogenase (ALDH5A1) is significantly increased in MS vs. control (n = 4, p < 0.05). The gene discussed is ALDH5A1; the disease is myeloid sarcoma.